Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Charles Lubner currently holds 11,050 shares of TETRAPHASE PHARMACEUTICALS INC (TTPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Charles Lubner has been a net seller of TTPH stock. They have purchased $24.7K and sold $2.5M worth of shares.
David Charles Lubner's most recent insider trade was on Jun 2, 2026, when they sold 11,050 shares at $0.00 per share.
David Charles Lubner serves as Executive at TETRAPHASE PHARMACEUTICALS INC (TTPH). They have executed 38 insider transactions totaling $2.5M over their tenure at the company.
David Charles Lubner holds the position of Executive at TETRAPHASE PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
David Charles Lubner has shown a selling trading pattern, with $24.7K in total purchases and $2.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Charles Lubner was on Apr 2, 2020, when they sold $749.9K worth of RARX shares. This transaction involved 15,622 shares at $48.00 per share.
David Charles Lubner currently owns 11,050 shares of TETRAPHASE PHARMACEUTICALS INC (TTPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Charles Lubner's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Charles Lubner has 38 Form 4 filings on record as an insider at TETRAPHASE PHARMACEUTICALS INC.
Set alerts for David Charles Lubner and 40,000+ other insiders.